Valturna is a prescription medication used to treat high blood pressure (“hypertension”) that combines two medications: aliskiren and valsartan. Unfortunately, a new study suggests that people who take this medication have a significantly higher risk of stroke, kidney failure, toxic levels of potassium (“hyperkalemia”), low blood pressure, and more.
Valturna Withdrawn from U.S. Market
April 19, 2012 — Novartis announced today that the company will voluntarily withdraw Valturna from the U.S. marketplace. The company had already ceased marketing of Valturna and recommended that physicians should not prescribe Valturna.
Valturna (aliskiren and valsartan) is a prescription medication used to treat high blood pressure (“hypertension”). It is actually a combination of two high blood pressure medications, which offers greater reduction of blood pressure than either drug alone. Valturna was created by the pharmaceutical company Novartis, and it was approved by the U.S. Food and Drug Administration (FDA) in 2009 to lower dangerously high blood pressure.